Optimized serodiagnosis of Mycoplasma pneumoniae infections

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 2, 2012, Pages 200-203

  Dumke, Roger ^a   Strubel, Andreas ^b   Cyncynatus, Camille ^c   Nuyttens, Hélène ^c   Herrmann, Richard ^d   Lück, Christian ^a   Jacobs, Enno ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b SEKISUI CHEMICAL CO LTD   (Japan)

^c InGen BioSciences   (France)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Community acquired pneumonia; Immunoblot; Mycoplasma pneumoniae; Recombinant proteins

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; GL PROTEIN; I PROTEIN; LMWP PROTEIN; P1 EPI PROTEIN; P1 PROTEIN; P200 PROTEIN; P400 PROTEIN; PDH B PROTEIN; PROTEIN P90; RP14 PROTEIN; RP3F PROTEIN; RP3M PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; MYCOPLASMA PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEROLOGY; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DNA, BACTERIAL; FEMALE; HUMANS; IMMUNOBLOTTING; INFANT; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RESPIRATORY SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84861186349     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.02.014     Document Type: Article

References (23)

1. Beersma M.F., Dirven K., van Dam A.P., Templeton K.E., Claas E.C., Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J Clin Microbiol 2005, 43:2277-2285.
2. Chaudhry R., Nisar N., Hora B., Chirasani S.R., Malhotra P. Expression and immunological characterization of the carboxy-terminal region of the P1 adhesin protein of Mycoplasma pneumoniae. J Clin Microbiol 2005, 43:321-325.
3. Csango P.A., Pedersen J.E., Hess R.D. Comparison of four Mycoplasma pneumoniae IgM-, IgG- and IgA-specific enzyme immunoassays in blood donors. Clin Microbiol Infect 2004, 10:1089-1104.
4. Dandekar T., Huynen M., Regula J.T., Ueberle B., Zimmermann C.U., Andrade M.A., et al. Re-annotating the Mycoplasma pneumoniae genome sequence: adding value, function and reading frames. Nucleic Acids Res 2000, 28:3278-3288.
5. Daxboeck F., Krause R., Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin Microbiol Infect 2003, 9:263-273.
6. Drasbek M., Nielsen P.K., Persson K., Birkelund S., Christiansen G. Immune response to Mycoplasma pneumoniae P1 and P116 in patients with atypical pneumonia analyzed by ELISA. BMC Microbiol 2004, 4:7.
7. Dumke R., Jacobs E. Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoniae. J Clin Microbiol 2009, 47:441-444.
8. Dumke R., Schurwanz N., Jacobs E. Characterisation of subtype- and variant-specific antigen regions of the P1 adhesin of Mycoplasma pneumoniae. Int J Med Microbiol 2008, 298:483-491.
9. Hammerschlag M.R. Mycoplasma pneumoniae infections. Curr Opin Infect Dis 2001, 14:181-186.
10. Jordan J.L., Chang H.Y., Balish M.F., Holt L.S., Bose S.R., Hasselbring B.M., et al. Protein P200 is dispensable for Mycoplasma pneumoniae hemadsorption but not gliding motility or colonization of differentiated bronchial epithelium. Infect Immun 2007, 75:518-522.
11. Regula J.T., Boguth G., Görg A., Hegermann J., Mayer F., Frank R., et al. Defining the mycoplasma "cytoskeleton": the protein composition of the Triton X-100 insoluble fraction of the bacterium Mycoplasma pneumoniae determined by 2-D gel electrophoresis and mass spectrometry. Microbiology 2001, 147:1045-1057.
12. Loens K., Goossens H., Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis 2010, 29:1055-1069.
13. Nilsson A.C., Björkman P., Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol 2008, 8:93-100.
14. Nir-Paz R., Michael-Gayego A., Ron M., Block C. Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection. Clin Microbiol Infect 2006, 12:685-688.
15. Nuyttens H., Cyncynatus C., Renaudin H., Pereyre S., Bebear C. Identification, expression and serological evaluation of the recombinant ATP synthase beta subunit of Mycoplasma pneumoniae. BMC Microbiol 2010, 10:216.
16. Proft T., Herrmann R. Identification and characterization of hitherto unknown Mycoplasma pneumoniae proteins. Mol Microbiol 1994, 13:337-348.
17. Proft T., Hilbert H., Plagens H., Herrmann R. The P200 protein of Mycoplasma pneumoniae shows common features with the cytadherence-associated proteins HMW1 and HMW3. Gene 1996, 171:79-82.
18. Schurwanz N., Jacobs E., Dumke R. A strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development. Infect Immun 2009, 77:5007-5015.
19. Sperker B., Hu P., Herrmann R. Identification of gene products of the P1 operon of Mycoplasma pneumoniae. Mol Microbiol 1991, 5:299-306.
20. Talkington D.F., Shott S., Fallon M.T., Schwartz S.B., Thacker W.L. Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 2004, 11:862-867.
21. von Baum H., Welte T., Marre R., Suttorp N., Lück C., Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis 2009, 9:62.
22. Waites K.B., Talkington D.F. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004, 17:697-728.
23. Yamazaki T., Narita M., Sasaski N., Kenri T., Arakawa Y., Sasaki T. Comparison of PCR for sputum samples obtained by induced cough and serological tests for diagnosis of Mycoplasma pneumoniae infection in children. Clin Vaccine Immunol 2006, 13:708-710.